About
Company Overview
Management Team
Board of Directors
Partnering
Careers
CBD
Programs
Overview
GvHD Program
Preclinical Programs
News
Investors
Investor Overview
Press Releases
Company Information
SEC Filings
Stock Information
Corporate Governance
Contact
About
Company Overview
Management Team
Board of Directors
Partnering
Careers
CBD
Programs
Overview
GvHD Program
Preclinical Programs
News
Investors
Investor Overview
Press Releases
Company Information
SEC Filings
Stock Information
Corporate Governance
Contact
Press Releases
Menu
Overview
Press Releases
Company Information
Stock Information
SEC Filings
Corporate Governance
Recent Press Releases
Kalytera Announces Issuance of Patent Covering the Use of CBD for the Treatment of Severe and Refractory Graft Versus Host Disease
April 19, 2018
Kalytera Retains Colwell Capital to Provide Investor Relations Services
April 10, 2018
Kalytera Initiates Program to Develop a Novel Cannabinoid-Based Compound for Treatment of Acute and Chronic Pain
March 20, 2018
Kalytera Announces Grant of Stock Options
January 31, 2018
Kalytera Announces Issuance of Shares under Services Agreement with The Salzman Group of Israel
January 26, 2018
Kalytera Announces Settlement of Debt Transaction
January 11, 2018
Kalytera Announces Approval of Shares for Services and Settlement of Debt Transaction with The Salzman Group of Israel
December 22, 2017
View all News and Insights
Browse by Year
2018
2017
2016
2015
